# A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis

> **NCT02401191** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 105 (actual)

## Conditions studied

- Rhinitis Allergic

## Interventions

- **DRUG:** FEX60/PE10

## Key facts

- **NCT ID:** NCT02401191
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2015-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401191, "A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02401191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*